Logos Global Management’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-145,089
Closed -$435K 60
2025
Q1
$435K Hold
145,089
0.08% 37
2024
Q4
$1.46M Hold
145,089
0.17% 45
2024
Q3
$2.13M Buy
+145,089
New +$2.13M 0.23% 47